M.‐A. Gall

2.3k total citations
19 papers, 1.8k citations indexed

About

M.‐A. Gall is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, M.‐A. Gall has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 5 papers in Nephrology. Recurrent topics in M.‐A. Gall's work include Diabetes Management and Research (7 papers), Diabetes Treatment and Management (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). M.‐A. Gall is often cited by papers focused on Diabetes Management and Research (7 papers), Diabetes Treatment and Management (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). M.‐A. Gall collaborates with scholars based in Denmark, United Kingdom and Sweden. M.‐A. Gall's co-authors include H.‐H. Parving, F. S. Nielsen, Philip Hougaard, K. Borch‐Johnsen, P. Fontaine, Kjeld Hermansen, Valentina Peterkova, Peter Rossing, U. Smidt and Allan Vaag and has published in prestigious journals such as Diabetes, Diabetologia and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M.‐A. Gall

19 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.‐A. Gall Denmark 16 1.1k 490 410 364 310 19 1.8k
James Ehrlich United States 17 489 0.4× 324 0.7× 704 1.7× 552 1.5× 208 0.7× 23 2.0k
Yu Cho Woo Hong Kong 25 944 0.9× 530 1.1× 90 0.2× 226 0.6× 155 0.5× 112 2.3k
J. Williamson Balfe Canada 23 297 0.3× 345 0.7× 554 1.4× 161 0.4× 140 0.5× 61 1.5k
S. D. Slater United Kingdom 13 962 0.9× 325 0.7× 48 0.1× 353 1.0× 400 1.3× 31 1.6k
Pia Clara Pafundi Italy 22 544 0.5× 239 0.5× 71 0.2× 375 1.0× 63 0.2× 75 1.7k
Giovanni Pellegrini Italy 18 412 0.4× 242 0.5× 298 0.7× 227 0.6× 80 0.3× 27 1.4k
Veena S. Rao United States 22 460 0.4× 459 0.9× 623 1.5× 1.1k 2.9× 96 0.3× 80 2.2k
Sonoo Mizuiri Japan 19 295 0.3× 212 0.4× 445 1.1× 396 1.1× 80 0.3× 84 1.3k
Clara Barrios Spain 17 201 0.2× 192 0.4× 362 0.9× 299 0.8× 43 0.1× 40 1.2k
Pierre Douville Canada 21 269 0.2× 394 0.8× 173 0.4× 147 0.4× 86 0.3× 55 1.3k

Countries citing papers authored by M.‐A. Gall

Since Specialization
Citations

This map shows the geographic impact of M.‐A. Gall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.‐A. Gall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.‐A. Gall more than expected).

Fields of papers citing papers by M.‐A. Gall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.‐A. Gall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.‐A. Gall. The network helps show where M.‐A. Gall may publish in the future.

Co-authorship network of co-authors of M.‐A. Gall

This figure shows the co-authorship network connecting the top 25 collaborators of M.‐A. Gall. A scholar is included among the top collaborators of M.‐A. Gall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.‐A. Gall. M.‐A. Gall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Russell‐Jones, David, et al.. (2015). Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials. Nutrition Metabolism and Cardiovascular Diseases. 25(10). 898–905. 46 indexed citations
2.
3.
Thomson, Alison H., Christine E. Staatz, C. M. Tobin, M.‐A. Gall, & Andrew Lovering. (2009). Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. Journal of Antimicrobial Chemotherapy. 63(5). 1050–1057. 120 indexed citations
4.
5.
Schoenle, Ε., et al.. (2007). Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. Diabetic Medicine. 24(1). 27–34. 111 indexed citations
6.
Spijkerman, Annemieke M. W., M.‐A. Gall, Lise Tarnow, et al.. (2007). Endothelial dysfunction and low‐grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabetic Medicine. 24(9). 969–976. 79 indexed citations
7.
Hollingdal, Malene, Jeppe Sturis, M.‐A. Gall, et al.. (2005). Repaglinide treatment amplifies first‐phase insulin secretion and high‐frequency pulsatile insulin release in Type 2 diabetes. Diabetic Medicine. 22(10). 1408–1413. 18 indexed citations
8.
9.
Rašlová, Katarı́na, et al.. (2004). Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Research and Clinical Practice. 66(2). 193–201. 173 indexed citations
10.
Parving, H.‐H., F. S. Nielsen, Lia E. Bang, et al.. (1996). Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia. 39(12). 1590–1597. 58 indexed citations
11.
Gall, M.‐A., K. Borch‐Johnsen, Philip Hougaard, F. S. Nielsen, & H.‐H. Parving. (1995). Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 44(11). 1303–1309. 267 indexed citations
12.
Gall, M.‐A., Peter Rossing, Allan Kofoed‐Enevoldsen, F. S. Nielsen, & H.‐H. Parving. (1994). Glomerular size-and charge selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 37(2). 195–201. 30 indexed citations
13.
Gall, M.‐A., et al.. (1993). [Severe megaloblastic anemia in child breast fed by a vegetarian mother].. PubMed. 40(1). 28–31. 2 indexed citations
14.
Gall, M.‐A., F. S. Nielsen, U. Smidt, & H.‐H. Parving. (1993). The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 36(10). 1071–1078. 120 indexed citations
15.
Hommel, E., P. H. Andersen, M.‐A. Gall, et al.. (1992). Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia. 35(5). 447–451. 71 indexed citations
16.
Gall, M.‐A., Peter Rossing, P. Damsbo, et al.. (1991). Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 34(9). 655–661. 285 indexed citations
17.
Vaag, Allan, Niels Eske Bruun, Ole Hother‐Nielsen, et al.. (1991). Effect of insulin on renal sodium handling in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance. Diabetologia. 34(4). 275–281. 56 indexed citations
18.
Mathiesen, E. R., M.‐A. Gall, E. Hommel, P. Skøtt, & H.‐H. Parving. (1989). Effects of Short‐term Strict Metabolic Control on Kidney Function and Extracellular Fluid Volume in Incipient Diabetic Nephropathy. Diabetic Medicine. 6(7). 595–600. 10 indexed citations
19.
Eden, Robert D., et al.. (1986). Pregnancy-induced hypertension and postpartum maternal morbidity.. PubMed. 68(1). 86–90. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Ehrlich Breakdown of academic impact, for papers by Yu Cho Woo Breakdown of academic impact, for papers by J. Williamson Balfe Breakdown of academic impact, for papers by S. D. Slater Breakdown of academic impact, for papers by Pia Clara Pafundi Breakdown of academic impact, for papers by Giovanni Pellegrini Breakdown of academic impact, for papers by Veena S. Rao Breakdown of academic impact, for papers by Sonoo Mizuiri Breakdown of academic impact, for papers by Clara Barrios Breakdown of academic impact, for papers by Pierre Douville
Rankless by CCL
2026